Lincomycin: a clinical study.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001407:Bacillus; D003877:Dermatitis, Contact / Q000188:drug therapy; D003967:Diarrhea / Q000139:chemically induced; D004697:Endocarditis, Bacterial / Q000188:drug therapy; D004754:Enterobacter; D005260:Female; D006193:Haemophilus influenzae; D006801:Humans; D007239:Infections / Q000188:drug therapy*; D008034:Lincomycin / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011008:Pneumococcal Infections / Q000188:drug therapy; D011014:Pneumonia / Q000188:drug therapy; D011015:Pneumonia, Aspiration / Q000188:drug therapy; D011018:Pneumonia, Pneumococcal / Q000188:drug therapy; D011565:Psoriasis / Q000188:drug therapy; D011711:Pyoderma / Q000188:drug therapy; D018805:Sepsis / Q000188:drug therapy; D013203:Staphylococcal Infections / Q000188:drug therapy; D013290:Streptococcal Infections / Q000188:drug therapy; D013296:Streptococcus pneumoniae
D008034:Lincomycin